301 related articles for article (PubMed ID: 30704223)
21. Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia.
Hernández-Boluda JC; Arellano-Rodrigo E; Cervantes F; Alvarez-Larrán A; Gómez M; Barba P; Mata MI; González-Porras JR; Ferrer-Marín F; García-Gutiérrez V; Magro E; Moreno M; Kerguelen A; Pérez-Encinas M; Estrada N; Ayala R; Besses C; Pereira A;
Ann Hematol; 2015 Jun; 94(6):911-8. PubMed ID: 25680896
[TBL] [Abstract][Full Text] [Related]
22. Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm.
Song IC; Yeon SH; Lee MW; Ryu H; Lee HJ; Yun HJ; Kim SY; Jo DY
Korean J Intern Med; 2021 Sep; 36(5):1190-1203. PubMed ID: 34289585
[TBL] [Abstract][Full Text] [Related]
23. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
[TBL] [Abstract][Full Text] [Related]
24. [Thrombosis in myeloproliferative neoplasms].
Asakura H
Rinsho Ketsueki; 2018; 59(8):1034-1041. PubMed ID: 30185703
[TBL] [Abstract][Full Text] [Related]
25. Acute coronary disease in essential thrombocythemia and polycythemia vera.
Rossi C; Randi ML; Zerbinati P; Rinaldi V; Girolami A
J Intern Med; 1998 Jul; 244(1):49-53. PubMed ID: 9698024
[TBL] [Abstract][Full Text] [Related]
26. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
[TBL] [Abstract][Full Text] [Related]
27. Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice.
Tefferi A; Barbui T
Mayo Clin Proc; 2015 Sep; 90(9):1283-93. PubMed ID: 26355403
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
29. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
Finazzi G; Barbui T
Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
[TBL] [Abstract][Full Text] [Related]
30. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
31. Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.
Garrote M; López-Guerra M; García-Pagán JC; Arellano-Rodrigo E; Ferrer-Marín F; Hernández-Boluda JC; Bellosillo B; Nomdedeu M; Hernández-Gea V; Triguero A; Guijarro F; Álamo J; Baiges A; Turon F; Colomer D; Cervantes F; Alvarez-Larrán A
Ann Hematol; 2024 Mar; 103(3):737-747. PubMed ID: 38263537
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms].
Han X; Bai BB; Feng CC; Zhao S; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):190-196. PubMed ID: 38387920
[TBL] [Abstract][Full Text] [Related]
33. Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?
Vianello F; Cella G; Osto E; Ballin A; Famoso G; Tellatin S; Iliceto S; Cucchini U; Saggiorato G; Omenetto E; Tona F
Am J Hematol; 2015 Feb; 90(2):109-13. PubMed ID: 25352381
[TBL] [Abstract][Full Text] [Related]
34. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
[TBL] [Abstract][Full Text] [Related]
35. Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
Ruggeri M; Rodeghiero F; Tosetto A; Castaman G; Scognamiglio F; Finazzi G; Delaini F; Micò C; Vannucchi AM; Antonioli E; De Stefano V; Za T; Gugliotta L; Tieghi A; Mazzucconi MG; Santoro C; Barbui T;
Blood; 2008 Jan; 111(2):666-71. PubMed ID: 17909074
[TBL] [Abstract][Full Text] [Related]
36. [When should a myeloproliferative syndrome be suggested in vascular medicine?].
Lazareth I; Delarue R; Priollet P
J Mal Vasc; 2005 Feb; 30(1):46-52. PubMed ID: 15924069
[TBL] [Abstract][Full Text] [Related]
37. Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
Podoltsev NA; Wang R; Shallis RM; Stempel JM; Di M; Neparidze N; Zeidan AM; Huntington SF; Giri S; Hull SC; Gore SD; Ma X
Cancer Med; 2023 Sep; 12(18):18889-18900. PubMed ID: 37702132
[TBL] [Abstract][Full Text] [Related]
38. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
Hernández-Boluda JC; Gómez M
Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
[TBL] [Abstract][Full Text] [Related]
39. Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up.
Ahlstrand E; Samuelsson J; Lindgren M; Pettersson H; Liljeholm M; Ravn-Landtblom A; Scheding S; Andréasson B
Eur J Haematol; 2020 Mar; 104(3):271-278. PubMed ID: 31863513
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.
Murphy S
Semin Hematol; 1999 Jan; 36(1 Suppl 2):9-13. PubMed ID: 9930551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
